Evidence map›Paper›PMID 24792928›Full record

ArticleJournal of lipid research2014

PKCδ-IRAK1 axis regulates oxidized LDL-induced IL-1β production in monocytes.

Rajiv Lochan Tiwari, Vishal Singh, Ankita Singh, Minakshi Rana, Anupam Verma, Nikhil Kothari, Monica Kohli, Jaishri Bogra, Madhu Dikshit, Manoj Kumar Barthwal

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. PKCδ regulates the vascular biology in diabetic atherosclerosis.Cell communication and signaling : CCS · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Rajiv Lochan TiwariPharmacology Division, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Vishal SinghPharmacology Division, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Ankita SinghPharmacology Division, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Minakshi RanaPharmacology Division, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Anupam VermaDepartment of Transfusion Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Nikhil KothariDepartment of Anaesthesia, King George's Medical University, Lucknow, India.
Monica KohliDepartment of Anaesthesia, King George's Medical University, Lucknow, India.
Jaishri BograDepartment of Anaesthesia, King George's Medical University, Lucknow, India.
Madhu DikshitPharmacology Division, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Manoj Kumar BarthwalPharmacology Division, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow, India.
Central Drug Research Institute · INKing George's Medical University · INCouncil of Scientific and Industrial Research · INSanjay Gandhi Post Graduate Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examined the role of interleukin (IL)-1 receptor-associated kinase (IRAK) and protein kinase C (PKC) in oxidized LDL (Ox-LDL)-induced monocyte IL-1β production. In THP1 cells, Ox-LDL induced time-dependent secretory IL-1β and IRAK1 activity; IRAK4, IRAK3, and CD36 protein expression; PKCδ-JNK1 phosphorylation; and AP-1 activation. IRAK1/4 siRNA and inhibitor (INH)-attenuated Ox-LDL induced secreted IL-1β and pro-IL-1β mRNA and pro-IL-1β and mature IL-1β protein expression, respectively. Diphenyleneiodonium chloride (NADPH oxidase INH) and N-acetylcysteine (free radical scavenger) attenuated Ox-LDL-induced reactive oxygen species generation, caspase-1 activity, and pro-IL-1β and mature IL-1β expression. Ox-LDL-induced secretory IL-1β production was abrogated in the presence of JNK INH II, Tanshinone IIa, Ro-31-8220, Go6976, Rottlerin, and PKCδ siRNA. PKCδ siRNA attenuated the Ox-LDL-induced increase in IRAK1 kinase activity, JNK1 phosphorylation, and AP-1 activation. In THP1 macrophages, CD36, toll-like receptor (TLR)2, TLR4, TLR6, and PKCδ siRNA prevented Ox-LDL-induced PKCδ and IRAK1 activation and IL-1β production. Enhanced Ox-LDL and IL-1β in systemic inflammatory response syndrome (SIRS) patient plasma demonstrated positive correlation with each other and with disease severity scores. Ox-LDL-containing plasma induced PKCδ and IRAK1 phosphorylation and IL-1β production in a CD36-, TLR2-, TLR4-, and TLR6-dependent manner in primary human monocytes. Results suggest involvement of CD36, TLR2, TLR4, TLR6, and the PKCδ-IRAK1-JNK1-AP-1 axis in Ox-LDL-induced IL-1β production.

Indexed as

AcetophenonesAcetylcysteineAdultBenzofuransBenzopyransCarbazolesFemaleHumansIndolesInterleukin-1betaInterleukin-1 Receptor-Associated KinasesLipoproteins, LDLMaleMiddle AgedMonocytesOnium CompoundsAcetophenonesAcetylcysteineBenzofuransBenzopyransCarbazolesdiphenyleneiodoniumGo 6976IL1B protein, humanIndolesInterleukin-1betaInterleukin-1 Receptor-Associated KinasesIRAK1 protein, humanLipoproteins, LDLOnium Compoundsoxidized low density lipoproteinPRKCD protein, humanProtein Kinase C-deltaReactive Oxygen SpeciesRo 31-8220rottlerintashinone IIAToll-Like Receptorsinflammationinterleukin-1 receptor-associated kinaseoxidized low density lipoproteinprotein kinase Cδ

Identifiers

PMID24792928
PMCPMC4076070
OpenAlexW2160018164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.